Analysts Set Oxford Instruments plc (LON:OXIG) Target Price at GBX 2,281

Oxford Instruments plc (LON:OXIGGet Free Report) has received a consensus rating of “Moderate Buy” from the six ratings firms that are currently covering the stock, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is GBX 2,281 ($28.40).

Separately, Shore Capital restated a “buy” rating on shares of Oxford Instruments in a report on Tuesday, April 16th.

Read Our Latest Analysis on Oxford Instruments

Oxford Instruments Trading Up 1.0 %

Oxford Instruments stock opened at GBX 2,105 ($26.20) on Tuesday. The stock has a market capitalization of £1.22 billion, a PE ratio of 2,043.69, a price-to-earnings-growth ratio of -3.56 and a beta of 0.97. Oxford Instruments has a 12-month low of GBX 20.70 ($0.26) and a 12-month high of GBX 2,884.80 ($35.91). The company has a debt-to-equity ratio of 16.33, a current ratio of 1.67 and a quick ratio of 1.11. The firm has a 50 day simple moving average of GBX 2,119.83 and a 200-day simple moving average of GBX 2,106.80.

About Oxford Instruments

(Get Free Report

Oxford Instruments plc designs and supplies technology products and services in Europe, North America, Asia, and internationally. It operates through three segments: Materials & Characterisation, Research & Discovery, and Service & Healthcare. The company offers atomic force, electron, and raman microscopy; deposition and etch tools; low temperature systems; optical imaging; nuclear magnetic resonance, modular optical spectroscopy; and x-ray.

See Also

Analyst Recommendations for Oxford Instruments (LON:OXIG)

Receive News & Ratings for Oxford Instruments Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Instruments and related companies with's FREE daily email newsletter.